Quantitative Research

A-H Premium Weekly (Sep 11th): Minsheng Bank, Innocare Pharma, Yofc, Citic Sec

11 Sep 2026 By Ke Yan, CFA, FRM
← All Research Reports

Abstract: We analyzed A-H premium changes across 196 dual-listed China stocks for the week ending September 11th, with the average A-H premium at 83.5%, up 1.7 percentage points week-on-week. The premium expansion was broad, with 121 stocks increasing versus 75 decreasing. Real Estate led sector gains at +3.8ppt while Health Care posted the largest sector decline at -0.9ppt. The top premium wideners were Drinda (+54.9ppt), Chenming Paper (+37.6ppt), Triumph New Energy (+35.3ppt), and Yofc (+23.9ppt), and the top narrowers were Fudanzhangjiang (-19.9ppt), Comec (-16.3ppt), Mabwell (-15.6ppt), and Innocare Pharma (-13.6ppt). Minsheng Bank reached a 52-week A-H premium high at 23.1% (+7.7ppt, z-score 3.0) and Citic Sec also hit a 52-week high at 23.2% (+4.8ppt).

INNOCARE PHARMA (9969 HK) CITIC SEC (6030 HK) MINSHENG BANK (1988 HK) YOFC (6869 HK)

Highlighted Stocks

INNOCARE PHARMA, CITIC SEC, MINSHENG BANK, YOFC

Series: A-H Premium Weekly: all issues →

More from A-H Premium Weekly

Interested in the full report? Get in touch with our team.